Login / Signup

Tissue plasminogen activator vs heparin for locking central venous catheters between apheresis procedures.

Gagan MathurSarah L MottLaura CollinsAnnette J Schlueter
Published in: Journal of clinical apheresis (2019)
For apheresis use, rt-PA and heparin CVC locks seem to have similar outcomes in preventing CVC malfunction. The convenience of not needing any flushes between procedures and overall cost of administering fewer locks favors rt-PA use when the interval between procedures is >7 days.
Keyphrases
  • venous thromboembolism
  • growth factor
  • metabolic syndrome